Glaucoma gene study backs InSite Vision's test
This article was originally published in Clinica
Executive Summary
A US study has produced powerful evidence to support using InSite Vision's OcuGene glaucoma gene test as a means of identifying patients in whom the disease is likely to progress rapidly.